Aβ initiates tau missorting, but persistent degeneration is then maintained by activated microglia through C1q/C3-CR3-mediated pruning and inflammatory remodeling. This model best explains continued synapse loss after amyloid reduction, though it may maintain degeneration more clearly than tau polarity failure itself.
Gut dysbiosis leads to LPS translocation, triggering intestinal and systemic inflammation via TLR4/MyD88/NF-κB signaling, promoting α-synuclein pathology. The peripheral gut barrier is the most viable intervention point, though CNS microglial TLR4 activation remains mechanistically tenuous. Best therapeutic approach: zonulin antagonists (larazotide) for gut barrier restoration combined with NLRP3 inflammasome inhibition rather than direct TLR4 blockade.
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
Unspecified Mechanismneurodegeneration
Convergent signals
No same-target convergence detected in this selection.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary
7/11
dimensions won
Microglia and complement sustain post-Aβ
6/11
dimensions won
LPS-TLR4-NF-κB Signaling Cascade as Ther
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.79
0.82
Evidence
0.76
0.58
Novelty
0.60
0.55
Feasibility
0.80
0.70
Impact
0.73
0.75
Druggability
0.70
0.70
Safety
0.48
0.68
Competition
0.55
0.75
Data
0.77
0.55
Reproducible
0.72
0.52
KG Connect
0.50
0.50
Score Breakdown
Dimension
Microglia and complement susta
LPS-TLR4-NF-κB Signaling Casca
Mechanistic
0.790
0.820
Evidence
0.760
0.580
Novelty
0.600
0.550
Feasibility
0.800
0.700
Impact
0.730
0.750
Druggability
0.700
0.700
Safety
0.480
0.680
Competition
0.550
0.750
Data
0.770
0.550
Reproducible
0.720
0.520
KG Connect
0.500
0.500
Evidence
Microglia and complement sustain post-Aβ neurodegeneration a
No evidence citations yet
LPS-TLR4-NF-κB Signaling Cascade as Therapeutic Target
No evidence citations yet
Debate Excerpts
Microglia and complement sustain post-Aβ neurodege
4 rounds · quality: 0.65
Theorist
1. **Title:** Fyn-anchored dendritic tau becomes self-sustaining after transient Aβ exposure
**Mechanism:** Aβ oligomers drive tau missorting from axon to dendritic spines, where tau binds **FYN** a...
Skeptic
Below the central skeptical point applies to all seven: current literature strongly supports that Aβ can induce dendritic/somatodendritic tau missorting and synaptic toxicity, but it does **not** clea...
Domain Expert
Most investable survivors are `6 > 4 > 1 > 2`. I would not spend serious translational budget yet on `7`, and I would treat `3` and `5` as modifier mechanisms rather than lead programs.
| Rank | Hypo...
Synthesizer
{"ranked_hypotheses":[{"title":"Tau missorting transitions into an autonomous tau-seeding state after transient Aβ exposure","description":"Transient Aβ exposure induces dendritic tau missorting that ...
LPS-TLR4-NF-κB Signaling Cascade as Therapeutic Ta
4 rounds · quality: 1.00
Theorist
# Mechanistic Hypotheses: Gut-Brain Axis in Parkinson's Disease
---
## Hypothesis 1: LPS-Induced TLR4/NF-κB Signaling Cascade Drives α-Synuclein Pathology
**Proposed Mechanism:**
Gut dysbiosis in P...
Skeptic
# Critical Evaluation of Gut-Brain Axis Hypotheses in Parkinson's Disease
## Overarching Methodological Concerns (Applicable to All Hypotheses)
Before examining individual hypotheses, several fundam...
Domain Expert
# Gut-Brain Axis in Parkinson's Disease: Therapeutic Development Assessment
## Executive Summary
Of the four mechanistic hypotheses proposed, none survives the skeptic's critique unscathed. However,...
Synthesizer
{"ranked_hypotheses":[{"title":"LPS-TLR4-NF-κB Signaling Cascade as Therapeutic Target","description":"Gut dysbiosis leads to LPS translocation, triggering intestinal and systemic inflammation via TLR...